Founder of the World Hepatitis Alliance appointed as Executive Director of the Medicines Patent Pool

19 Apr 2018 Bridie Taylor

Charles Gore continues his legacy of improving access to treatment for people living with hepatitis B and C 

Today the Medicines Patent Pool (MPP) announced the appointment of Charles Gore as the new MPP Executive Director. Charles takes up the role after two decades of advocating on behalf of people living with viral hepatitis on both the national and global stage.

After founding the World Hepatitis Alliance (WHA) in 2007, he served for 10 years as WHA President. Under his leadership, WHA mobilised patient organisations across the globe and pushed through three World Health Assembly resolutions: the first made World Hepatitis Day one of just four disease-specific global awareness days officially endorsed by the World Health Organization (WHO), the second pushed countries to establish national plans and finally, in the 2016 resolution, governments adopted the global strategy and, critically, the goal of elimination by 2030. During his time as President, Charles strengthened WHA’s relations with key partners such as WHO and spearheaded the World Hepatitis Summit. After three terms, Charles stepped down as President in December 2017 and was succeeded by Michael Ninburg.

In accepting the position as Executive Director of MPP, Charles leaves the Hepatitis C Trust, the first UK-based charity for people living with hepatitis C, where he has been CEO for the last 17 years. In this role, he led the Hepatitis C Trust’s efforts, which culminated last year in the commitment of the UK to eliminate hepatitis C by 2030 and in January this year in the commitment by NHS to agree a deal with the pharmaceutical industry that will enable elimination by 2025.

“As a patient-led and patient-driven organisation, we cannot think of a better person to lead the Medicines Patent Pool,” says Karine Belondrade, WHA COO/Acting CEO. “People affected by viral hepatitis have always been the driving force behind Charles’ tireless efforts to rid the world of one of the greatest global health threats. With him steering the ship, we hope that millions of others will benefit and secure access to life-saving treatments. We wish him all the very best in the new role and look forward to a continued partnership with the Medicines Patent Pool.”